Liming Qiu, Andrew Chang, Ruoyu Ma, Theresa V Strong, Michael S Okun, Kelly D Foote, Anna Wexler, Aysegul Gunduz, Jennifer L Miller, Casey H Halpern
Prader-Willi syndrome (PWS) is a complex, genetic disorder characterized by multisystem involvement, including hyperphagia, maladaptive behaviors and endocrinological derangements. Recent developments in advanced neuroimaging have led to a growing understanding of PWS as a neural circuit disorder, as well as subsequent interests in the application of neuromodulatory therapies. Various non-invasive and invasive device-based neuromodulation methods, including vagus nerve stimulation (VNS), transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), and deep brain stimulation (DBS) have all been reported to be potentially promising treatments for addressing the major symptoms of PWS...
March 1, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics